Moran Lavie

418 total citations
24 papers, 254 citations indexed

About

Moran Lavie is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Moran Lavie has authored 24 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Moran Lavie's work include Respiratory viral infections research (6 papers), Neonatal Respiratory Health Research (5 papers) and Respiratory Support and Mechanisms (5 papers). Moran Lavie is often cited by papers focused on Respiratory viral infections research (6 papers), Neonatal Respiratory Health Research (5 papers) and Respiratory Support and Mechanisms (5 papers). Moran Lavie collaborates with scholars based in Israel, Canada and United States. Moran Lavie's co-authors include Israel Amirav, Keren Armoni Domany, Liora Sagi, Aviva Fattal‐Valevski, Nael Elias, Tabea Menchen, Heymut Omran, Huda Mussaffi, Avraham Avital and Claudius Werner and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and Human Mutation.

In The Last Decade

Moran Lavie

23 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moran Lavie Israel 9 108 63 54 43 40 24 254
K.W. Southern United Kingdom 7 209 1.9× 119 1.9× 31 0.6× 20 0.5× 75 1.9× 20 348
P Macchia Italy 9 176 1.6× 25 0.4× 33 0.6× 33 0.8× 42 1.1× 19 282
Klaus Hackner Austria 11 71 0.7× 35 0.6× 20 0.4× 19 0.4× 19 0.5× 28 271
J C Chang United States 5 67 0.6× 48 0.8× 42 0.8× 85 2.0× 40 1.0× 6 315
Ben Anderson United States 12 161 1.5× 63 1.0× 49 0.9× 82 1.9× 117 2.9× 25 414
Michele Manion United Kingdom 7 358 3.3× 50 0.8× 27 0.5× 38 0.9× 110 2.8× 11 459
Nicoletta Cantarutti Italy 10 39 0.4× 99 1.6× 16 0.3× 82 1.9× 25 0.6× 27 358
Ivo Šlapák Czechia 8 55 0.5× 70 1.1× 32 0.6× 54 1.3× 35 0.9× 23 311
Santosh Rai India 8 59 0.5× 34 0.5× 12 0.2× 56 1.3× 10 0.3× 63 252
Carla S. Walti Switzerland 8 123 1.1× 87 1.4× 12 0.2× 7 0.2× 49 1.2× 16 326

Countries citing papers authored by Moran Lavie

Since Specialization
Citations

This map shows the geographic impact of Moran Lavie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moran Lavie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moran Lavie more than expected).

Fields of papers citing papers by Moran Lavie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moran Lavie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moran Lavie. The network helps show where Moran Lavie may publish in the future.

Co-authorship network of co-authors of Moran Lavie

This figure shows the co-authorship network connecting the top 25 collaborators of Moran Lavie. A scholar is included among the top collaborators of Moran Lavie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moran Lavie. Moran Lavie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lavie, Moran, Keren Armoni Domany, Inbal Golan‐Tripto, et al.. (2024). Respiratory outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy: national real-world cohort study. European Journal of Pediatrics. 184(1). 58–58. 2 indexed citations
2.
Amirav, Israel, et al.. (2022). A case of an unfortunate tooth fairy visit to a ventilator‐dependent child. Pediatric Pulmonology. 57(6). 1555–1556. 1 indexed citations
3.
Goldbart, Aviv, Moran Lavie, Ronit Lubetzky, et al.. (2022). Inhaled Nitric Oxide for the Treatment of Acute Bronchiolitis: A Multicenter Randomized Controlled Clinical Trial to Evaluate Dose Response. Annals of the American Thoracic Society. 20(2). 236–244. 11 indexed citations
4.
Golan‐Tripto, Inbal, Moran Lavie, Dario Prais, et al.. (2022). High flow nasal cannula therapy in the pediatric home setting. Pediatric Pulmonology. 58(3). 941–948. 4 indexed citations
5.
Lior, Yotam, Yuval Yogev, Reut Riff, et al.. (2022). Fractional exhaled Nitric Oxide (FeNO) level as a predictor of COVID-19 disease severity. Nitric Oxide. 124. 68–73. 16 indexed citations
6.
Amirav, Israel, et al.. (2022). Translation of the quality of life questionnaire for primary ciliary dyskinesia (QOL‐PCD) into Hebrew: The Israeli experience. Pediatric Pulmonology. 57(5). 1331–1338. 3 indexed citations
7.
Amirav, Israel, et al.. (2022). Unforeseen changes in seasonality of pediatric respiratory illnesses during the first COVID‐19 pandemic year. Pediatric Pulmonology. 57(6). 1425–1431. 9 indexed citations
8.
Amirav, Israel, et al.. (2022). Asthma risk after a pediatric intensive care unit admission for respiratory syncytial virus bronchiolitis. Pediatric Pulmonology. 57(7). 1677–1683. 5 indexed citations
9.
Amirav, Israel & Moran Lavie. (2021). Spurious Asthma Presentation during COVID-19. Children. 9(1). 5–5.
10.
Amirav, Israel, et al.. (2021). High fractional exhaled nitric oxide levels in asthma patients: Does size matter?. Pediatric Pulmonology. 56(6). 1449–1454. 6 indexed citations
11.
Lavie, Moran, et al.. (2021). Respiratory syncytial virus bronchiolitis among refugees and asylum seekers from war‐torn countries. Pediatric Pulmonology. 56(9). 2888–2892. 2 indexed citations
12.
Amirav, Israel, et al.. (2021). Real‐time effects of COVID‐19 pandemic lockdown on pediatric respiratory patients. Pediatric Pulmonology. 56(6). 1401–1408. 16 indexed citations
13.
Domany, Keren Armoni, et al.. (2020). The Effect of Mepolizumab on the Lungs in a Boy with Hypereosinophilic Syndrome. American Journal of Respiratory and Critical Care Medicine. 202(2). e34–e35. 3 indexed citations
14.
Goldbart, Aviv, Inbal Golan‐Tripto, Giora Pillar, et al.. (2020). Inhaled nitric oxide therapy in acute bronchiolitis: A multicenter randomized clinical trial. Scientific Reports. 10(1). 9605–9605. 20 indexed citations
15.
Lavie, Moran, et al.. (2020). Nusinersen for spinal muscular atrophy type 1: Real‐world respiratory experience. Pediatric Pulmonology. 56(1). 291–298. 38 indexed citations
16.
Amirav, Israel & Moran Lavie. (2019). Rethink Respiratory Rate for Diagnosing Childhood Pneumonia. EClinicalMedicine. 12. 6–7. 5 indexed citations
17.
Amirav, Israel, et al.. (2019). Fractional exhaled Nitric Oxide levels: an objective indicator for asthma severity. PA5420–PA5420. 1 indexed citations
18.
Amirav, Israel, Julia Wallmeier, Niki T. Loges, et al.. (2016). Systematic Analysis ofCCNOVariants in a Defined Population: Implications for Clinical Phenotype and Differential Diagnosis. Human Mutation. 37(4). 396–405. 62 indexed citations
19.
Amarilyo, Gil, Miguel Glatstein, Arik Alper, et al.. (2012). IV Penicillin G Is as Effective as IV Cefuroxime in Treating Community-Acquired Pneumonia in Children. American Journal of Therapeutics. 21(2). 81–84. 7 indexed citations
20.
Westbroek, Wendy, Aharon Klar, Andrew R. Cullinane, et al.. (2011). Cellular and clinical report of new Griscelli syndrome type III cases. Pigment Cell & Melanoma Research. 25(1). 47–56. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.W. Southern Breakdown of academic impact, for papers by P Macchia Breakdown of academic impact, for papers by Klaus Hackner Breakdown of academic impact, for papers by J C Chang Breakdown of academic impact, for papers by Ben Anderson Breakdown of academic impact, for papers by Michele Manion Breakdown of academic impact, for papers by Nicoletta Cantarutti Breakdown of academic impact, for papers by Ivo Šlapák Breakdown of academic impact, for papers by Santosh Rai Breakdown of academic impact, for papers by Carla S. Walti
Rankless by CCL
2026